Paid Clinical Trials Buffalo
Discover 640 paid clinical trials in Buffalo, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Endovascular Therapy for Low NIHSS Ischemic Strokes
Sponsor:
Emory University
Location:
Code:
NCT04167527
Conditions
Cerebral Ischemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Immediate mechanical thrombectomy(iMT) using EmboTrap Revascularization Device
Initial medical management (iMM)
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Sponsor:
Pfizer
Location:
Code:
NCT05145127
Conditions
Hemophilia A
Hemophilia B
Eligibility Criteria
Sex: Male
Age: 1 - 70+
Healthy Volunteers: Not accepted
Interventions
PF-06741086
A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)
Sponsor:
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Location:
Code:
NCT04471727
Conditions
Small-Cell Lung Cancer
Neuroendocrine Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
MK-6070
Atezolizumab
Ifinatamab Deruxtecan (I-DXd)
Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers
Sponsor:
Intercytex
Location:
Code:
NCT00232973
Conditions
Leg Ulcer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ICXP007
A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Sponsor:
Pediatric Brain Tumor Consortium
Location:
Code:
NCT04978727
Conditions
Medulloblastoma
Glioblastoma Multiforme
Anaplastic Astrocytoma
High-grade Astrocytoma NOS
Anaplastic Oligodendroglioma
Eligibility Criteria
Sex: All
Age: 1 - 21
Healthy Volunteers: Not accepted
Interventions
SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥1 and <10 years
SurVaxM for patients with non-relapsed DIPG post radiation-therapy ages ≥1 and ≤21 years
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04181060
Conditions
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
Stage IIIB Lung Cancer AJCC v8
Stage IV Lung Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bevacizumab
Biospecimen Collection
Computed Tomography
Echocardiography
Magnetic Resonance Imaging
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
Sponsor:
Alzheimer's Disease Cooperative Study (ADCS)
Location:
Code:
NCT06223360
Conditions
Alzheimer Disease
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Not accepted
Interventions
Low Dose Benfotiamine
High Dose Benfotiamine
Placebo
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
Sponsor:
Children's Oncology Group
Location:
Code:
NCT05705531
Conditions
Cardiovascular Disorder
Clonal Hematopoiesis
Hodgkin Lymphoma
Eligibility Criteria
Sex: All
Age: 7 - 40
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Electronic Health Record Review
Magnetic Resonance Imaging
Survey Administration
Improving Geriatric Drug Safety in Underserved Practices
Sponsor:
Agency for Healthcare Research and Quality (AHRQ)
Location:
Code:
NCT00277173
Conditions
Cardiovascular Diseases
Eligibility Criteria
Sex: All
Age: 65+
Healthy Volunteers: Not accepted
Interventions
Adoption of Crew Resource Management approach